Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, facilitating targeted treatment or absorption of the active ingredients. The gel-like consistency of the medication is used to treat conditions such as Actinic Keratosis, Basal Cell Carcinoma, Bowen's Disease, Molluscum Contagiosum, and Squamous Cell Carcinoma.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the compounded formulation of Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel, a specialized medication designed to address a range of skin conditions. This unique formulation combines the potent effects of two active ingredients, Imiquimod and Deoxy-D-Glucose, which synergistically work to alleviate the symptoms associated with various skin diseases.
Imiquimod serves as an immune response modifier, aiding in the reduction of inflammation and stimulating the body's inherent healing mechanisms. On the other hand, Deoxy-D-Glucose acts as an anti-inflammatory agent, effectively reducing redness and swelling. The combined action of these two ingredients provides a comprehensive approach to skin treatment.
This compounded formulation is indicated for the treatment of a variety of skin conditions, including actinic keratosis, basal cell carcinoma, and superficial squamous cell carcinoma. The Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel is applied directly to the affected area, ensuring targeted treatment and absorption of the active ingredients.
What sets this formulation apart is its semisolid state, dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, ensuring that the active ingredients are delivered in a gel-like consistency for optimal absorption and effectiveness.
Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel is a appropriate treatment option for a multitude of skin conditions. It is crucial to adhere to the instructions provided by your healthcare provider when using this medication. If you have any queries about this formulation or its application, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you in your journey towards better skin health.
This compounded formulation of Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel is a semisolid preparation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, ensuring targeted treatment or absorption of the active ingredients. This formulation is primarily used for the treatment of actinic keratosis, superficial basal cell carcinoma, and external genital warts. However, it is not indicated for the treatment of internal genital warts and should not be used for any other purpose.
Patients are advised to apply the gel to the affected area once daily for 3 days, followed by 4 days of no treatment. This treatment cycle should be repeated until the desired response is achieved. It is crucial to avoid contact with the eyes, mouth, and other mucous membranes during application.
It is worth noting that this formulation may cause local skin reactions, including redness, itching, burning, and swelling. If these reactions become severe or persist, patients should immediately contact their healthcare provider. To minimize potential skin damage, patients are also advised to avoid sun exposure and use sunscreen while using this formulation.
Patients should also avoid using other topical medications, cosmetics, or other products on the treated area while using this formulation. If you have any questions about this formulation or its use, please do not hesitate to reach out for further information.
Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel is a compounded formulation that combines two potent active ingredients to effectively treat a range of skin conditions. Imiquimod, an immune response modifier, stimulates the body's immune system to combat infections or diseases. On the other hand, Deoxy-D-Glucose serves as an anti-inflammatory agent, reducing inflammation and redness associated with various skin conditions.
This topical gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients. It is typically applied once or twice daily, depending on the severity of the condition. The gel should be gently rubbed into the affected area until it is fully absorbed. It is crucial to wash your hands after application to prevent the spread of the infection to other body parts.
Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel is used to treat a variety of skin conditions, including actinic keratosis, basal cell carcinoma, and genital warts.
While generally well-tolerated, some individuals may experience side effects such as redness, itching, burning, or irritation at the application site. If these side effects occur, it is important to contact your healthcare provider immediately.
If you have any questions about Imiquimod 5%/Deoxy-D-Glucose 0.2% Topical Gel or its mechanism of action, please do not hesitate to reach out to us at Bayview Pharmacy.
This is a compounded formulation that combines Imiquimod at 5% concentration and Deoxy-D-Glucose at 0.2% concentration. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin.
The gel has a semisolid, gel-like consistency that allows for easy application and absorption into the skin.
You should apply this gel directly to the affected area of the skin as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
The active ingredients in this gel are Imiquimod at a concentration of 5% and Deoxy-D-Glucose at a concentration of 0.2%.
Imiquimod is an immune response modifier that works by stimulating the immune system to fight certain skin conditions. Deoxy-D-Glucose is a glucose molecule that has been modified to interfere with the metabolism of certain cells, making it useful in treating various conditions.
This gel is intended for topical use only and should be applied to the affected area as directed by your healthcare provider. It should not be used on sensitive areas such as the eyes, mouth, or genitals unless specifically instructed by a healthcare professional.
If you experience any side effects such as redness, swelling, or irritation at the application site, stop using the gel and contact your healthcare provider immediately.
If you are pregnant or breastfeeding, you should consult your healthcare provider before using this gel. The effects of the active ingredients on unborn babies or nursing infants are not fully known.
This gel should be stored at room temperature, away from heat and direct light. Keep the container tightly closed when not in use.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
